TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07601425: Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Sponsor: Atavistik Bio, Inc · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 100 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$931,260

Rescue Site Savings

+$620,840

Unlock Full NCT07601425 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07601425 Rescue Dossier →